scholarly article | Q13442814 |
P356 | DOI | 10.1016/0006-8993(80)90564-8 |
P698 | PubMed publication ID | 7370750 |
P2093 | author name string | G J Dockray | |
P433 | issue | 1 | |
P1104 | number of pages | 11 | |
P304 | page(s) | 155-165 | |
P577 | publication date | 1980-04-01 | |
P1433 | published in | Brain Research | Q4955782 |
P1476 | title | Cholecystokinins in rat cerebral cortex: identification, purification and characterization by immunochemical methods | |
P478 | volume | 188 |
Q67285472 | A soluble interaction between dibutyryl cyclic guanosine 3′:5′-monophosphate and cholecystokinin: A possible mechanism for the inhibition of cholecystokinin activity |
Q30439465 | Analysis of neuropeptide expression and localization in adult drosophila melanogaster central nervous system by affinity cell-capture mass spectrometry |
Q48690386 | Binding specificity of the mouse cerebral cortex receptor for small cholecystokinin peptides |
Q90130243 | Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat |
Q35172234 | Cell-type-specific CCK2 receptor signaling underlies the cholecystokinin-mediated selective excitation of hippocampal parvalbumin-positive fast-spiking basket cells |
Q54495436 | Changes in brain cholecystokinin octapeptide following lesions of the medial forebrain bundle |
Q48632452 | Characterization of Cholecystokinin from the Human Brain |
Q60050266 | Cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-d-aspartate antagonists phencyclidine and dizocilpine maleate |
Q77339780 | Cholecystokinin and morphine-induced hypothermia |
Q72665070 | Cholecystokinin and substance P immunoreactivity in retinas of rats, frogs, lizards and chicks |
Q40092916 | Cholecystokinin in the central nervous system: A minireview |
Q59078196 | Cholecystokinin octapeptide in the rat hypothalamo-neurohypophysial system |
Q71054903 | Cholecystokinin-Like Bioactivity in Rat Cerebral Cortex |
Q37609678 | Cholecystokinin-immunoreactive neurons in rat and monkey cerebral cortex make symmetric synapses and have intimate associations with blood vessels |
Q72934002 | Cholecystokinin-like immunoreactivity in frog retina: Localization, characterization, and biosynthesis |
Q33804759 | Cholecystokinin/opioid interactions |
Q34420892 | Cholecystokinin: a multi-functional molecular switch of neuronal circuits |
Q40885950 | Control of c-fos expression in STC-1 cells by peptidomimetic stimuli |
Q48403870 | Depolarizing action of cholecystokinin on rat supraoptic neurones in vitro |
Q48665280 | Distribution and Chromatographic Characterisation of Gastrin and Cholecystokinin in the Rat Central Nervous System |
Q72654134 | Distribution and development of peptidergic nerves and gut endocrine cells in mice with congenital aganglionic colon, and their normal littermates |
Q48640393 | Distribution and projections of cholecystokinin-immunoreactive neurons in the hypothalamic paraventricular nucleus of rat. |
Q48773145 | Distribution of cholecystokinin immunoreactivity in the BALB/c mouse forebrain: an immunocytochemical study |
Q42004408 | Distribution of cholecystokinin-immunoreactive cell bodies in the male and female rat: I. Hypothalamus |
Q70268049 | Distribution of the VIP-like immunoreactive neurons in the cat central nervous system |
Q51629970 | Effect of synthetic trypsin inhibitor on plasma immunoreactive cholecystokinin in rats. |
Q49028452 | Effects of cholecystokinin on Y, X, and W cells in the dorsal lateral geniculate nucleus of rats |
Q48414498 | Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. |
Q48874115 | Evidence that cholecystokinin is a neurotransmitter of olfaction in nucleus olfactorius anterior |
Q48665292 | Extraction Techniques for Gastrins and Cholecystokinins in the Rat Central Nervous System |
Q35387802 | Extraction and immunochemical characterization of cholecystokinin-like peptides from pig and rat brain |
Q48736119 | Gastrin/cholecystokinin-like immunoreactive peptides in the Dungeness crab, Cancer magister (Dana): immunochemical and biological characterization |
Q37014370 | Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. Diminished concentrations in patients with celiac disease |
Q52519727 | Immunocytochemical mapping of gastrin/CCK-like peptides in the neuroendocrine system of the blowfly Calliphora vomitoria (Diptera). |
Q48694071 | In vitro, release of cholecystokinin from hypothalamus and frontal cortex of Sprague-Dawley, Zucker lean (Fa/-) and obese (fa/fa) rats |
Q70200819 | In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin |
Q52296046 | Influence of sulfated and unsulfated cholecystokinin octapeptide on conditioned feeding behaviour in rats. |
Q42240437 | Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration |
Q48493730 | Intracerebroventricular administration of cholecystokinin inhibits the activity of the dopaminergic and serotoninergic systems of the brain |
Q69590167 | Isolation from chicken antrum, and primary amino acid sequence of a novel 36-residue peptide of the gastrin/CCK family |
Q72940790 | Low binding of Bolton-Hunter-labelled cholecystokinin-33 to carboxyl-terminal CCK-antibodies |
Q41541665 | Nature of immunoreactive CCK in rat and pig brain |
Q52103086 | Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes |
Q53237947 | Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein--initial observations. |
Q53955384 | Neuropeptides in the gut: quantification and characterization of cholecystokinin octapeptide-, bombesin- and vasoactive intestinal polypeptide-like immunoreactivities in the myenteric plexus of the guinea-pig small institute. |
Q54257727 | Neurotensin, substance P, gastrin/cholecystokinin, and bombesin in the Intestine of the Tilapia ( Oreochromis mossambicus ) and the Goldfish ( Carassius auratus ): Immunochemical detection and effects on electrophysiological characteristics |
Q48712380 | Neurotransmitter candidates of somatosensory primary afferent fibres |
Q44331717 | New vertebrate brain--gut peptide related to a molluscan neuropeptide and an opioid peptide |
Q33792380 | PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes |
Q72520484 | Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons |
Q77537755 | Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin-positive interneurones in CA1 of the adult rat hippocampus |
Q70671363 | Plasma cholecystokinin concentrations in patients with pancreatic insufficiency measured by sequence-specific radioimmunoassays |
Q36314928 | Post-translational processing of cholecystokinin in pig brain and gut. |
Q48463338 | Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain |
Q72912353 | Preparation and characterization of a probe for the cholecystokinin octapeptide receptor, N alpha (125I-desaminotyrosyl)CCK-8, and its interactions with pancreatic acini |
Q34620212 | Preprocholecystokinin processing in the normal human anterior pituitary |
Q48751857 | Regional differences in the development of cholecystokinin-like activity in rat brain |
Q72506357 | Regional distributions of somatostatin and cholecystokinin-like immunoreactivities in rat and bovine brain |
Q40610040 | Regulation by neuroprotective factors of NMDA receptor mediated nitric oxide synthesis in the brain and retina |
Q48789295 | Regulation of CCK release in cerebral cortex by N-methyl-D-aspartate receptors: Sensitivity to APV, MK-801, kynurenate, magnesium and zinc lons |
Q71301132 | Reversed-phase high-performance liquid chromatography and separation of peptide hormones in human tissues and plasma with reference to cholecystokinins |
Q72664058 | Substance P and Cholecystokinin-Like Peptides in Helix Neurons and Cholecystokinin and Serotonin in a Giant Neuron |
Q72415636 | Sulphated cholecystokinin octapeptide inhibits ethanol consumption in the rat |
Q54538986 | The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus |
Q41727605 | The cholecystokinin gene is abundantly co-expressed with gastrin-releasing peptide, enkephalin and neuropeptide Y genes in a clonal human neuroepithelioma cell line |
Q46677237 | The distribution of cholecystokinin-like immunoreactive neurons and nerve terminals in the retrohippocampal region in the rat and guinea pig |
Q67285486 | The mechanism by which dibutyryl cyclic GMP antagonizes the action of cholecystokinin |
Q71046660 | The release of rat intestinal cholecystokinin after oral trypsin inhibitor measured by bio-assay |
Q72915526 | Transport of cholecystokinin-octapeptide-like immunoreactivity toward the gut in afferent vagal fibres in cat and dog |
Q48207788 | VIP- and CCK-like-immunoreactive neurons in the hedgehog (Erinaceus europaeus) and sheep (Ovis aries) brain |
Search more.